Although IL-6 can have anti-tumor effects in the early phases of melanoma progression, in the later stages, IL-6 promotes tumor angiogenesis and recruits immunosuppressive myeloid cells to the tumor microenvironment (8, 12, 13, 24). This evidence concerns the gene IL6 and neoplasm.